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Introduction: Maternal factor V Leiden status is associated with fetal loss. Due to the uncertain 
etiology of the disorder and the lack of established criteria for more precise risk stratification, 
prophylactic anticoagulation during pregnancy is a subject of intense debate. We have recently 
developed a mouse model of pregnancy disorder in factor V Leiden mothers, establishing a cause-
effect relation for the epidemiologic association. We exploit this model to identify risk modifiers of 
fetal loss in factor V Leiden mothers and to characterize disease pathogenesis. 
Methods: Genetic and histological approaches were used to clarify disease pathogenesis. Placental 
perfusion was assessed by intravenous FITC-dextran injections. Platelet depleting antibodies were 
used to examine the role of maternal platelets in fetal loss. 
Results: We show that: (1) Fetal defects in thrombomodulin and endothelial protein C receptor 
genes precipitate pregnancy loss in factor V Leiden mothers; the same mutations in the factor V 
Leiden animal are compatible with normal functioning of other vascular compartments. (2) 
Heterozygous deficiency of tissue factor pathway inhibitor is inconsequential with respect to fetal 
loss. (3) Fetal loss is caused by disruption of placental morphogenesis at the stage of labyrinth layer 
formation, and occurs in the absence of overt thrombosis or perfusion defects. (4) Platelet depletion 
or genetic elimination of the thrombin receptor Par4 from the mother allows normal placentation and 
prevents fetal loss. 
Conclusions: Our results identify fetal gene defects in the thrombomodulin-protein C pathway as 
risk modifiers of fetal loss in factor V Leiden mothers; show the existence of vascular bed-specific 
pathogenic mechanisms in the placenta; and identify platelets and the thrombin receptor Par4 as 
critical mediators of fetal loss, likely involving a pathogenic mechanism independent of occlusive 
thrombosis. This model provides an opportunity to test the efficacy of anti-thrombotic and anti-
platelet treatments. 
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